Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer

Surgery Today

Volumn 41, Issue 2, 2011, Pages 175-182

  Miura, Koh ^a   Fujibuchi, Wataru ^b   Ishida, Kazuyuki ^c   Naitoh, Takeshi ^a   Ogawa, Hitoshi ^a   Ando, Toshinori ^a   Yazaki, Nobuki ^a   Watanabe, Kazuhiro ^a   Haneda, Sho ^a   Shibata, Chikashi ^a   Sasaki, Iwao ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinical trial; Colorectal cancer; Diagnostic marker; Inhibitor of apoptosis protein family; Therapeutic target

Indexed keywords

1 (2 METHOXYETHOXY) 2 METHYL 3 (2 PYRAZINYLMETHYL)NAPHTHO[2,3 D]IMIDAZOLE 4,9 DIONE; 1 (2 METHOXYETHYL) 2 METHYL 4,9 DIOXO 3 (PYRAZIN 2 YLMETHYL) 4,9 DIHYDRO 1H NAPHTHO[2,3 D]IMIDAZOLIUM BROMIDE; AEG 35156; ANTINEOPLASTIC AGENT; AT 406; BIOLOGICAL MARKER; CASPASE; CYCLIN D1; DEXAMETHASONE; FAS ANTIGEN; FLOXURIDINE; FLUOROURACIL; IDRONOXIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; IRINOTECAN; LIVIN; LY 2181308; PEPTIDE VACCINE; PEPTIDOMIMETIC AGENT; SM 122; SM 164; SM 337; SURVIVIN; SURVIVIN PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; APOPTOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELLULAR DISTRIBUTION; COLON BIOPSY; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; DIAGNOSTIC VALUE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; DRUG TOLERABILITY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LOCAL METASTASIS; LYMPHOMA; MELANOMA; NICK END LABELING; NONHUMAN; PANCREAS CANCER; PREDICTION; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS;

EID: 79951655008     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4390-1     Document Type: Review

References (49)

1. D.M. Parkin F. Bray J. Ferlay P. Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. J.A. Meyerhardt R.J. Mayer 2005 Systemic therapy for colorectal cancer N Engl J Med 352 476 487 1:CAS:528:DC%2BD2MXptlWkuw%3D%3D 10.1056/NEJMra040958 15689586 (Pubitemid 40175974)
3. A. Bedi P.J. Pasricha A.J. Akhtar J.P. Barber G.C. Bedi F.M. Giardiello, et al. 1995 Inhibition of apoptosis during development of colorectal cancer Cancer Res 55 1811 1816 1:CAS:528:DyaK2MXltlSgsbw%3D 7728743
4. A.M. Hunter E.C. LaCasse R.G. Korneluk 2007 The inhibitors of apoptosis (IAPs) as cancer targets Apoptosis 12 1543 1568 1:CAS:528:DC%2BD2sXotFWru7c%3D 10.1007/s10495-007-0087-3 17573556 (Pubitemid 47106887)
5. M.G. Hinds R.S. Norton D.L. Vaux C.L. Day 1999 Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat Nat Struct Biol 6 648 651 1:CAS:528:DyaK1MXksVenu74%3D 10.1038/10701 10404221 (Pubitemid 29318954)
6. C. Sun M. Cai A.H. Gunasekera R.P. Meadows H. Wang J. Chen, et al. 1999 NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP Nature 401 818 822 1:CAS:528:DyaK1MXntFaqtLk%3D 10.1038/44617 10548111 (Pubitemid 29512521)
7. S.J. Martin 2001 Dealing the CARDs between life and death Trends Cell Biol 11 188 189 1:STN:280:DC%2BD3Mzhs12jtA%3D%3D 10.1016/S0962-8924(01)01971-7 11393153 (Pubitemid 32367867)
8. M. Gyrd-Hansen M. Darding M. Miasari M.M. Santoro L. Zender W. Xue, et al. 2008 IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis Nat Cell Biol 10 1309 1317 1:CAS:528:DC%2BD1cXhtlais7jJ 10.1038/ncb1789 18931663
9. B. Vischioni P. van der Valk S.W. Span F.A. Kruyt J.A. Rodriguez G. Giaccone 2006 Expression and localization of inhibitor of apoptosis proteins in normal human tissues Hum Pathol 37 78 86 1:CAS:528:DC%2BD2MXhtlajtLrL 10.1016/j.humpath.2005.09.022 16360419 (Pubitemid 41790506)
10. T. Ponnelle C. Chapusot L. Martin C. Bonithon-Kopp A.M. Bouvier S. Plenchette, et al. 2003 Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis Pathol Res Pract 199 723 731 1:CAS:528:DC%2BD2cXitFWjurk%3D 10.1078/0344-0338-00488 14708638 (Pubitemid 38016417)
11. T. Endo S. Abe H.B. Seidlar S. Nagaoka T. Takemura M. Utsuyama, et al. 2004 Expression of IAP family proteins in colon cancers from patients with different age groups Cancer Immunol Immunother 53 770 776 1:CAS:528: DC%2BD2cXmt1KrtLk%3D 10.1007/s00262-004-0534-8 15138717 (Pubitemid 39149903)
12. I. Tamm S.M. Kornblau H. Segall S. Krajewski K. Welsh S. Kitada, et al. 2000 Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias Clin Cancer Res 6 1796 1803 1:CAS:528: DC%2BD3cXktVWis7k%3D 10815900 (Pubitemid 30305074)
13. G. Qi H. Tuncel E. Aoki S. Tanaka S. Oka I. Kaneko, et al. 2009 Intracellular localization of survivin determines biological behavior in colorectal cancer Oncol Rep 22 557 562 1:CAS:528:DC%2BD1MXhtVOmt7jI 19639203
14. H.Y. Chang X. Yang 2000 Proteases for cell suicide: functions and regulation of caspases Microbiol Mol Biol Rev 64 821 846 1:CAS:528: DC%2BD3MXltFWjtrY%3D 10.1128/MMBR.64.4.821-846.2000 11104820 (Pubitemid 32475932)
15. P. Fuentes-Prior G.S. Salvesen 2004 The protein structures that shape caspase activity, specificity, activation and inhibition Biochem J 384 201 232 1:CAS:528:DC%2BD2cXhtVSqs7rP 10.1042/BJ20041142 15450003 (Pubitemid 39656233)
16. C. Adrain S.J. Martin 2001 The mitochondrial apoptosome: a killer unleashed by the cytochrome seas Trends Biochem Sci 26 390 397 1:CAS:528:DC%2BD3MXkt1Kht7o%3D 10.1016/S0968-0004(01)01844-8 11406413 (Pubitemid 32530658)
17. Q.L. Deveraux N. Roy H.R. Stennicke T. Van Arsdale Q. Zhou S.M. Srinivasula, et al. 1998 IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases EMBO J 17 2215 2223 1:CAS:528:DyaK1cXivFOmsb8%3D 10.1093/emboj/17.8.2215 9545235 (Pubitemid 28171907)
18. H. Karasawa K. Miura W. Fujibuchi K. Ishida N. Kaneko M. Kinouchi, et al. 2009 Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells Cancer Sci 100 903 913 1:CAS:528: DC%2BD1MXls1Srtbc%3D 10.1111/j.1349-7006.2009.01112.x 19302291
19. C. Du M. Fang Y. Li L. Li X. Wang 2000 Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 33 42 1:CAS:528:DC%2BD3cXkvFCrsbc%3D 10.1016/S0092-8674(00) 00008-8 10929711
20. M.M. Santoro T. Samuel T. Mitchell J.C. Reed D.Y. Stainier 2007 Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis Nat Genet 39 1397 1402 1:CAS:528:DC%2BD2sXht1aqurnN 10.1038/ng.2007.8 17934460 (Pubitemid 350035006)
21. E. Varfolomeev J.W. Blankenship S.M. Wayson A.V. Fedorova N. Kayagaki P. Garg, et al. 2007 IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis Cell 131 669 681 1:CAS:528:DC%2BD2sXhsVSgurzF 10.1016/j.cell.2007.10.030 18022362 (Pubitemid 350087204)
22. M. Rothe M.G. Pan W.J. Henzel T.M. Ayres D.V. Goeddel 1995 The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins Cell 83 1243 1252 1:CAS:528:DyaK28XhsVOmsA%3D%3D 10.1016/0092-8674(95)90149-3 8548810 (Pubitemid 26007814)
23. E. Dejardin 2006 The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development Biochem Pharmacol 72 1161 1179 1:CAS:528:DC%2BD28XhtVagtrzN 10.1016/j.bcp.2006.08.007 16970925 (Pubitemid 44479741)
24. G. Ambrosini C. Adida D.C. Altieri 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 917 921 1:CAS:528:DyaK2sXltVylt7w%3D 10.1038/nm0897-917 9256286 (Pubitemid 27353455)
25. D. Vucic W.J. Fairbrother 2007 The inhibitor of apoptosis proteins as therapeutic targets in cancer Clin Cancer Res 13 5995 6000 1:CAS:528: DC%2BD2sXhtFygs7vP 10.1158/1078-0432.CCR-07-0729 17947460 (Pubitemid 350075054)
26. Y.J. Fang Z.H. Lu G.Q. Wang Z.Z. Pan Z.W. Zhou J.P. Yun, et al. 2009 Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer Int J Colorectal Dis 24 875 884 1:STN:280:DC%2BD1MvjtVemtA%3D%3D 10.1007/s00384-009-0725-z 19421758
27. Y.Y. Lee C.P. Yu C.K. Lin S. Nieh K.F. Hsu H. Chiang, et al. 2009 Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters Dis Markers 26 9 18 1:CAS:528: DC%2BD1MXitFyrsbk%3D 19242064
28. K. Søreide E. Gudlaugsson I. Skaland E.A. Janssen B. Van Diermen H. Körner, et al. 2008 Metachronous cancer development in patients with sporadic colorectal adenomas - multivariate risk model with independent and combined value of hTERT and survivin Int J Colorectal Dis 23 389 400 10.1007/s00384-007-0424-6 18189140
29. A.I. Sarela N. Scott J. Ramsdale A.F. Markham P.J. Guillou 2001 Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas Ann Surg Oncol 8 305 310 1:STN:280:DC%2BD3M3lsVWgug%3D%3D 10.1007/s10434-001-0305-0 11352303 (Pubitemid 32422855)
30. G. Xiang X. Wen H. Wang K. Chen H. Liu 2009 Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis J Surg Oncol 100 708 712 1:CAS:528:DC%2BC3cXht1agsr8%3D 10.1002/jso.21408 19777490
31. F. De Oliveira Lima H. De Oliveira Costa L.F. Barrezueta C.T. Fujiyama Oshima J.A. Silva Jr T.S. Gomes, et al. 2009 Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis Oncol Rep 22 295 303 19578769
32. M. Krajewska H. Kim C. Kim H. Kang K. Welsh S. Matsuzawa, et al. 2005 Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new apoptotic biomarkers Clin Cancer Res 11 5451 5461 1:CAS:528:DC%2BD2MXmvFSmtbg%3D 10.1158/1078-0432.CCR-05-0094 16061861 (Pubitemid 41060821)
33. S. Lassmann L. Tang M. Capanu T. Brabletz A. Schöpflin A. Zur Hausen, et al. 2007 Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy Gastroenterology 133 1831 1839 1:CAS:528:DC%2BD1cXnt1KqsA%3D%3D 10.1053/j.gastro.2007.08.075 18054556 (Pubitemid 350180803)
34. C. Terzi A.E. Canda O. Sagol K. Atila D. Sonmez M. Fuzun, et al. 2008 Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy Int J Colorectal Dis 23 37 45 10.1007/s00384-007-0376-x 17805549 (Pubitemid 350142358)
35. D.T. McDowell F.M. Smith J.V. Reynolds S.G. Maher C. Adida P. Crotty, et al. 2009 Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer Int J Colorectal Dis 24 1261 1269 10.1007/s00384-009-0755-6 19593573
36. K. Miura H. Karasawa I. Sasaki 2009 cIAP2 as a therapeutic target in colorectal cancer and other malignancies Expert Opin Ther Targets 13 1333 1345 1:CAS:528:DC%2BD1MXhtlSltL7M 10.1517/14728220903277256 19793002
37. T. Nakahara M. Takeuchi I. Kinoyama T. Minematsu K. Shirasuna A. Matsuhisa, et al. 2007 YM155, a novel small-molecule survivin suppressant, induces regression of established human hormonerefractory prostate tumor xenografts Cancer Res 67 8014 8021 1:CAS:528:DC%2BD2sXpvFKjt7g%3D 10.1158/0008-5472.CAN-07-1343 17804712 (Pubitemid 47395135)
38. T. Iwasa I. Okamoto M. Suzuki T. Nakahara K. Yamanaka E. Hatashita, et al. 2008 Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines Clin Cancer Res 14 6496 6504 1:CAS:528:DC%2BD1cXht1KgtbnO 10.1158/1078-0432.CCR-08-0468 18927289
39. F. Rödel B. Frey W. Leitmann G. Capalbo C. Weiss C. Rödel 2008 Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 247 255 10.1016/j.ijrobp.2008.02.011 18406888 (Pubitemid 351491424)
40. E.C. LaCasse G.G. Cherton-Horvat K.E. Hewitt L.J. Jerome S.J. Morris E.R. Kandimalla, et al. 2006 Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis Clin Cancer Res 12 5231 5241 1:CAS:528:DC%2BD28XovF2gtrY%3D 10.1158/1078-0432.CCR-06-0608 16951243 (Pubitemid 44453353)
41. D.A. Silasi A.B. Alvero T.J. Rutherford D. Brown G. Mor 2009 Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs Expert Opin Pharmacother 10 1059 1067 1:CAS:528:DC%2BD1MXktlGis7k%3D 10.1517/14656560902837980 19364253
42. M.W. Saif E. Tytler F. Lansigan D.M. Brown A.J. Husband 2009 Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers Expert Opin Investig Drugs 18 469 479 1:CAS:528:DC%2BD1MXjvVWns7k%3D 10.1517/13543780902762835 19278301
43. G. Wu J. Chai T.L. Suber J.W. Wu C. Du X. Wang, et al. 2000 Structural basis of IAP recognition by Smac/DIABLO Nature 408 1008 1012 1:CAS:528:DC%2BD3MXhslahsQ%3D%3D 10.1038/35050012 11140638 (Pubitemid 32101651)
44. L. Li R.M. Thomas H. Suzuki J.K. De Brabander X. Wang P.G. Harran 2004 A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death Science 305 1471 1474 1:CAS:528:DC%2BD2cXntFartL8%3D 10.1126/science.1098231 15353805 (Pubitemid 39167668)
45. W. Sun Z. Nikolovska-Coleska D. Qin H. Sun C.Y. Yang L. Bai, et al. 2009 Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases J Med Chem 52 593 596 1:CAS:528:DC%2BD1MXksV2juw%3D%3D 10.1021/jm801101z 19138149
46. Ascenta Therapeutics. http://www.ascenta.com/development/index.php#at406.
47. B. Pajak B. Gajkowska A. Orzechowski 2009 Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-alpha-dependent extrinsic apoptosis Apoptosis 14 203 217 1:CAS:528:DC%2BD1MXpvVersA%3D%3D 10.1007/s10495-008-0291-9 19130237
48. S.M. Kim S.Y. Lee D.Y. Yuk D.C. Moon S.S. Choi Y. Kim, et al. 2009 Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel Arch Pharm Res 32 755 765 1:CAS:528: DC%2BD1MXmtlOjtb8%3D 10.1007/s12272-009-1515-4 19471891
49. M.J. An J.H. Cheon S.W. Kim E.S. Kim T.I. Kim W.H. Kim 2009 Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts Cancer Lett 279 93 100 1:CAS:528: DC%2BD1MXltlejt7s%3D 10.1016/j.canlet.2009.01.026 19232820